炎症性肠病全球流行病学变迁:维持21世纪可持续的医疗服务
手术率因有效治疗可及性提高等因素出现暂时下降,但医疗费用持续增加。文章提出实现21世纪全球可持续IBD医疗服务的必要步骤。
要点
- IBD已成为全球疾病,新工业化国家发病率上升。
- 手术率暂时下降,但医疗费用持续增加。
- 环境与微生物组因素为疾病预防提供机会。
核心结论
- 克罗恩病和溃疡性结肠炎已成为全球疾病,需采取步骤实现21世纪可持续的IBD医疗服务。
研究设计与样本
- 综述,未报告系统检索范围。
主要发现
- 近几十年新工业化国家生活方式西化,IBD发病率上升。
- 手术率出现暂时下降,部分归因于医疗治疗可及性增加、更早启动有效治疗及临床实践变化。
- IBD相关医疗费用持续增加,部分因治疗费用高昂。
- 稳健的流行病学和实验研究明确了外部环境和微生物组在疾病发病中的作用,为通过修改这些因素预防疾病提供了机会。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Crohn's disease and ulcerative colitis have emerged as global diseases. They affect over 2 million individuals in the North America, 3.2 million in Europe, and millions more worldwide. The recent decades have been characterized by several important changes in the epidemiology of these diseases, in particularly an increasing incidence rates in newly industrialized countries experiencing a westernization of lifestyle. While rates of surgery have experienced a temporal decline attributable in part to increasing availability of medical treatments, earlier initiation of effective therapy, and changes in clinical practice, the healthcare costs associated with these diseases have continued to increase, in part due to costly therapies. Robust epidemiologic and experimental studies have defined the role of the external environment and microbiome on disease pathogenesis and have offered opportunities for disease prevention by modifying such factors. We propose several important steps that are necessary to provide globally sustainable inflammatory bowel disease care in the 21st century.
引用
- Ananthakrishnan AN, Kaplan GG, Ng SC, et al. Changing Global Epidemiology of Inflammatory Bowel Diseases: Sustaining Health Care Delivery Into the 21st Century. Clin Gastroenterol Hepatol. 2020. PMID: 32007542. doi:10.1016/j.cgh.2020.01.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。